جست‌وجوی استاد و پژوهشگر

• Genetics
• Gene Editing
• Molecular Biology
• +۳ مورد دیگر

Timothy Nottoli, PhD, is a Senior Research Scientist in the Department of Comparative Medicine at Yale University, and Co-Director of the Yale Genome Editing Center (YGEC). He holds a PhD from the University of California, Berkeley (1992) and a BA from the University of California, Santa Barbara (1985). His research focuses on genome editing, mouse models for disease mechanisms, and genetic regulation in developmental and evolutionary contexts. Dr. Nottoli collaborates extensively with investigators like James Noonan and Shuichi Ahsan, advancing studies in gene therapy, cardiovascular malformations, and genetic disorders such as systemic lupus erythematosus and microvillus inclusion disease. His work integrates CRISPR-based tools to engineer precise genetic modifications in mice, enabling disease modeling and therapeutic testing. Key projects include enhancing AsCas12a knock-in efficiency for immunogenetics studies and exploring evolutionary innovations in regulatory elements linked to developmental genes. His lab’s contributions span molecular biology, epigenetics, and translational medicine, with implications for personalized therapies and understanding genetic pathways. Dr. Nottoli’s academic roles include co-directing the YGEC, fostering interdisciplinary genome-editing initiatives. He has authored over 30 peer-reviewed publications, addressing topics like DNA repair mechanisms, hypertension pathophysiology, and genomic instability. His research emphasizes translational applications, such as developing mouse models to study human diseases and testing pharmacological interventions (e.g., isradipine for aldosteronism). Collaborative networks extend to departments like Neurosurgery and Genetics, reflecting his commitment to team science. Professional activities include advising on genomic tools and mentoring researchers in gene-editing techniques. His lab, part of the Yale School of Medicine, is located at the Anlyan Center. Contact details include an academic office phone (203.737.4325) and email for collaborations. No formal awards are listed, though his impactful contributions to genome editing are recognized through his publications and institutional roles.

• Cardiovascular Development
• Stem Cell Biology
• Regenerative Medicine
• +۳ مورد دیگر

Makoto Sahara is an Adjunct Associate Professor in the Department of Surgery at Yale School of Medicine. He holds an MD from Osaka University (1998) and a PhD from Tokyo University (2007). His research focuses on cardiovascular development, stem cell biology, and regenerative medicine, particularly exploring molecular mechanisms underlying cardiomyogenesis and vasculogenesis during heart development. Dr. Sahara has pioneered studies using bioengineering strategies for cardiac repair and employs cutting-edge techniques like single-cell RNA sequencing to analyze cardiac cell populations. Key research areas include: 1) Molecular regulation of vascular smooth muscle differentiation in embryonic heart development, 2) Role of paracrine mediators in cardiac regeneration, 3) Identification of essential genes (e.g., ZIC2, STRA6) controlling cardiac progenitor cell fate, and 4) Development of mRNA-based assays for studying proteasomal degradation pathways in cardiomyopathies. His work bridges basic science and translational medicine, with over 45 peer-reviewed publications and 1,447 citations. Dr. Sahara collaborates extensively with institutions globally, contributing to advancements in heart regeneration research and stem cell applications. His lab focuses on translating discoveries in developmental cardiology into novel therapeutic strategies for cardiovascular diseases. Current projects emphasize bioengineered cardiac tissues and CRISPR-based functional genomics approaches.

Sandra Shefelbineمشاهده پروفایل

استاد

• Bone Biomechanics
• Mechano-Adaptation
• Musculoskeletal Mechanobiology
• +۳ مورد دیگر

Sandra J. Shefelbine is an Associate Dean of Space and Special Initiatives in the Office of the Dean at Northeastern University's College of Engineering. She holds dual professorships in Mechanical and Industrial Engineering and Bioengineering. Her research focuses on multi-scale bone biomechanics and mechano-adaptation mechanisms, with particular emphasis on how mechanical signals influence bone and joint development. She leads the Shefelbine Lab, which integrates experimental, computational, and engineering approaches to study skeletal tissues across multiple scales. Education: PhD (2002) Mechanical Engineering, Stanford University; MPhil (1998) Engineering Design, Cambridge University; BSE (1997) Mechanical and Aerospace Engineering, Princeton University Affiliations: Institute for Chemical Imaging of Living Systems; Institute for Mechanobiology Research Interests Her work explores bone's hierarchical structure and mechano-adaptive responses, including: - Musculoskeletal Mechanoadaptation : Bone's response to mechanical loading through cellular signaling pathways. - Advanced Technologies : Developing novel imaging and computational tools (e.g., BoneJ open-source software). - Multiscale Mechanics : Linking molecular-level changes to macroscopic mechanical properties in bone and cartilage. Awards 2020 Fulbright Futures Scholarship American Institute for Medical and Biological Engineers Fellow (2020) Imperial College London Rector’s Medal for Teaching Excellence (2011) Research Projects & Grants Her lab leads NSF-funded projects on: In Vivo Mechanotransduction During Limb Growth Manipulating Fluid Flow in Bone Adaptation Joint Morphogenesis in Axolotl Limb Regeneration The lab also collaborates on biomechanical studies of aging, obesity, and regenerative medicine. Contact: s.shefelbine@northeastern.edu , 617-373-3199

• Bioluminescence
• Marine Biology
• Fungal Biology
• +۳ مورد دیگر

Anderson Oliveira is an Assistant Professor of Chemistry at Stern College, Yeshiva University. His research focuses on bioluminescence in diverse organisms, including fungi, marine invertebrates, and deep-sea organisms. He investigates biochemical mechanisms, ecological functions, and applications of bioluminescence in environmental monitoring and biotechnology. Key research areas include fungal circadian rhythms influencing luminescence, marine bioluminescent systems (e.g., ctenophores, polychaetes), and the development of bioluminescent bioassays for toxicology studies. His work spans chemical characterization of luminescent compounds, evolutionary convergence of light-emitting systems, and ecological implications of bioluminescence in biodiversity. Recent studies highlight discoveries such as green-light-emitting photoproteins in ctenophores and first reports of bioluminescence in sipunculan worms. Oliveira’s research bridges fundamental biology with applied science, contributing to environmental monitoring tools and understanding of light-driven ecological interactions. He advises no listed students and has no explicitly mentioned awards. His affiliation with Yeshiva University’s Stern College positions him at the intersection of chemistry, marine biology, and fungal biology, emphasizing interdisciplinary approaches to bioluminescence studies.

Francesco Di Virgilioمشاهده پروفایل

استاد بالینی

• Inflammation
• Neuroinflammation
• Cytokines
• +۵ مورد دیگر

Francesco Di Virgilio is a Clinical Professor at the University of Ferrara , affiliated with the Medical School and Department of Morphology, Surgery and Experimental Medicine. He has held leadership roles including Deputy Rector for Research, Dean for Education, and Departmental Chairman. Medical Doctor (MD) from University of Padova (1979) His research spans Inflammation , Neuroinflammation , Purinergic receptors , and Cancer immunology , focusing on P2X7 receptor mechanisms, cell death pathways , and immunometabolism . He has contributed to understanding apoptosis and necrosis in disease and ATP signaling . Notable awards include membership in the European Academy of Tumor Immunology (2016) and Faculty of 1000 (2012). He serves on editorial boards for journals like Inflammation , Purinergic Signalling , and American Journal of Physiology-Cell Physiology . Scientific Awards : Member of the European Academy of Tumor Immunology (2016), Member of Faculty of 1000 (2012) His 239 PubMed-indexed articles and 4 international patents highlight his work on innate immunity , metabolic disorders , and cancer .

Geiszt Miklósمشاهده پروفایل

استاد

• NADPH oxidases
• Molecular Physiology
• Peroxidases
• +۴ مورد دیگر

Miklós Geiszt is a Professor of Physiology at Semmelweis University's Medical School since 2015. He holds dual roles as researcher and educator with over 30 years of academic service. His primary affiliation is the Department of Physiology, where he has held progressively senior roles including Assistant Professor (1997-2007) and Associate Professor (2007-2015). Education: MD (summa cum laude, 1993), PhD in Cellular & Molecular Physiology (1998) from Semmelweis University. Completed additional training at NIH's Laboratory of Host Defenses (1999-2002). Credentials include USMLE certifications and a Hungarian Unlimited Medical License. Research focuses on NADPH oxidase enzymes (Nox/Duox families), peroxidase functions, and redox biology. Key areas include collagen crosslinking mechanisms, endoplasmic reticulum redox regulation, and host defense systems. Over 30 peer-reviewed articles and 7 mentored PhD graduates demonstrate his impactful contributions. Award-winning educator with honors for tutoring excellence (2012), research distinction (Huzella Award 2019), and grants including Momentum Grant (2011). His work has advanced understanding of oxidative stress mechanisms in physiological and pathological conditions. Teaching spans 30+ years, including medical physiology instruction for Hungarian and international students. Maintains active laboratory research with collaborations at NIH and international conferences.

Ole Kiehnمشاهده پروفایل

استاد

• Cellular Neurophysiology
• Systems Neurophysiology
• Motor System Neuroscience
• +۵ مورد دیگر

Ole Kiehn is a distinguished Professor in Integrative Neuroscience at the Department of Neuroscience, University of Copenhagen, and Professor in Neuroscience at Karolinska Institutet, Sweden. His career spans over three decades with significant contributions to understanding the neural basis of movement. He leads the Kiehn Lab which focuses on the molecular, cellular, and network organization of locomotor circuits in mammals. Education: 2002: Docent, Karolinska Institutet, Sweden 1990: Doctor of Science from University of Copenhagen, Denmark 1985: M.D. from University of Copenhagen, Denmark Kiehn's research centers on cellular and systems neurophysiology applied to the motor system, with particular focus on elucidating the networks underlying locomotion in rodents. His work bridges the gap between neuronal circuit organization and behavior, investigating how spinal locomotor circuits are activated and controlled by descending command signals. Recent work has focused on the functional organization of key neuronal elements for limbed locomotion in mammals: rhythm generation, coordination of flexors and extensors, and left/right coordination. His research has strong translational potential for developing therapies for movement disorders caused by trauma or disease. Analysis of Kiehn's recent publications reveals consistent focus on the neural circuitry controlling locomotion. His work spans multiple levels of analysis from molecular and cellular mechanisms to systems-level organization of motor circuits. A significant theme is the modular organization of locomotor networks, with studies examining specific neuronal populations that control different aspects of movement. His research increasingly integrates advanced techniques like optogenetics, chemogenetics, and transcriptomics to dissect the complex neural circuits underlying movement. Scientific Awards: 2024: Novo Nordic Foundation's Laureate program award 2022: The Brain Prize 2021: Kirsten and Freddy Johansen's preclinical prize 2019: Lundbeck Foundation's Professorship award 2017: Novo Nordic Foundation's Laureate program award 2015: European Research Council Advanced Grant 2014: Member of the European Molecular Biology Organization (EMBO) 2012: Member of The Royal Swedish Academy of Sciences Kiehn has supervised over 10 PhD students and more than 25 postdocs throughout his career. His research has been supported by numerous prestigious grants including multiple European Research Council Advanced Grants, Novo Nordisk Foundation Laureate grants, and Lundbeck Foundation Professorship grants. He has served in leadership roles including as Vice Chair of Research at the Department of Neuroscience, UCPH, and as President Elect for the Federation of European Neuroscience Societies (FENS). The Kiehn Lab, located at the University of Copenhagen, is a leading center for research on locomotor circuitry. The lab employs a broad experimental repertoire including production of transgenic mouse lines, genetically driven tracing, mRNA sequencing, in vitro and in vivo electrophysiology, optogenetics, and advanced behavioral analyses. Current research focuses on understanding the molecular, cellular, and network diversification of locomotor circuitries in mammals, with applications to movement disorders and spinal cord injury.

Oleg Krishtalمشاهده پروفایل

استاد

• Cellular Neurophysiology
• Membrane Biophysics
• Ion Channel Pharmacology
• +۳ مورد دیگر

Oleg Krishtal is Professor and Head of the Department of Cellular Membranology at the Bogomoletz Institute of Physiology in Kyiv, Ukraine, and also serves as the Institute’s Acting Director. A full member of the National Academy of Sciences of Ukraine (1997) and of Academia Europaea (1990), he has spent more than five decades investigating ion channels, synaptic transmission and neuropharmacology. Education: University degree in Molecular Physics (1968) PhD in Molecular Physics (1971) Doctor of Sciences (1981) Professor (1982) Corresponding Member, Ukrainian Academy of Sciences (1985) Corresponding Member, Russian Academy of Sciences (1987) Full Member, National Academy of Sciences of Ukraine (1997) Member, Academia Europaea (1990) Research Interests: Prof. Krishtal’s work focuses on the biophysics of ion channels and synaptic transmission in the mammalian brain. Early studies identified proton-gated and ATP-gated channels in sensory neurons, laying the foundation for understanding purinergic signalling. Later work dissected the roles of P2X, AMPA, NMDA and GABA A receptors in hippocampal and cortical circuits, and explored how plant-derived compounds (ginkgolides, hyperforin, kava constituents) modulate these receptors. His laboratory combines patch-clamp electrophysiology with molecular pharmacology to uncover mechanisms of synaptic plasticity, neuroprotection and nociception. Publication Trends: Between 2000 and 2004 alone, Prof. Krishtal’s team produced >40 papers primarily in Journal of Neuroscience , European Journal of Neuroscience , Neuropharmacology and Biophysical Journal . These articles converge on three major themes: (i) P2X receptor-mediated synaptic currents and their contribution to LTP, (ii) modulation of glutamatergic and GABAergic transmission by natural products, and (iii) calcium-channel pharmacology in cerebellar and hippocampal neurons. The work bridges fundamental ion-channel biophysics to potential therapeutic applications in neuroprotection and pain. Scientific Awards & Distinctions: State Prize of the USSR for Science (1983) Member of the National Academy of Sciences of Ukraine (1997) Member of Academia Europaea (1990) Corresponding Member of the Ukrainian Academy of Sciences (1985) Corresponding Member of the Russian Academy of Sciences (1987) Editorial & Professional Service: Editorial Board member: European Journal of Neuroscience Editorial Board member: Neuroscience Editorial Board member: Autonomic Neuroscience Editorial Board member: Purinergic Signalling Laboratory & Collaborations: Prof. Krishtal heads the Department of Cellular Membranology at Bogomoletz Institute, a leading Ukrainian centre for cellular neuroscience. The lab houses patch-clamp rigs, live-cell imaging and molecular facilities, and maintains active collaborations with Kyushu University, Harvard, Complutense University of Madrid and the University of Pennsylvania, evidenced by his visiting professorships there.

Rohini Kunerمشاهده پروفایل

استاد

• Pain Research
• Nervous System Plasticity
• Molecular Pharmacology
• +۳ مورد دیگر

Rohini Kuner serves as Professor and Chair of the Department of Molecular Pharmacology at Heidelberg University's Medical Faculty, Germany, a position held since 2006 with prior directorship of the Institute of Pharmacology (2009-2012). Her academic journey spans international institutions including University of Iowa (PhD) and Max-Planck Institute. Education: 1987-1991: Pharmaceutical Technology, University of Bombay 1994: PhD in Pharmacology, University of Iowa (Supervisor: Prof. G.F. Gebhart) 2005: Habilitation in Pharmacology and Toxicology, Heidelberg University Research Focus: Professor Kuner's work pioneers molecular mechanisms of chronic pain, investigating nervous system plasticity in neurological disorders through neuropharmacological approaches. Her laboratory identifies critical pathways involving calcium signaling, synaptic scaffolding proteins, and tumor-nerve interactions that drive persistent pain states. Publication Trends: Recent works (2013-2009) reveal consistent exploration of inflammatory and cancer pain mechanisms, with emphasis on genomic regulation in spinal neurons, hematopoietic factors in bone pain, and receptor subunit dynamics. These studies bridge molecular discoveries with clinical pain management applications. Scientific Recognition: ERC Advanced Investigator Grant (2011) Pat Wall International Young Investigator Award (2010) National Basic Pain Research Award (2007) Rudolf-Buchheim Prize (2005) Multiple early-career awards (2006-2008) Leadership & Service: As Coordinator of Research Area C in the Excellence Cluster 'CellNetworks', she directs interdisciplinary neuroscience initiatives. Her editorial leadership includes Section Editor for 'Pain' and Associate Editor for 'European Journal of Neuroscience', alongside service on DFG research panels and ERC grant committees.

Markus M. Lerchمشاهده پروفایل

استاد

• Pathophysiology of pancreatic disorders
• Cell biology of the pancreas
• Genetics of pancreatic diseases
• +۳ مورد دیگر

Markus M. Lerch, MD FRCP, is Professor of Medicine, Physician-in-Chief and Chief Operating Officer at LMU University Hospital Munich, one of Europe’s premier academic medical centres. Since 2021 he has led clinical, educational and research activities of this 2 200-bed institution while continuing a prolific personal research programme. Prior to Munich he served from 2007-2020 as Professor and Chair of the Department of Medicine A at University Medicine Greifswald, preceded by professorial and senior consultant roles at the Universities of Münster, Homburg/Saar, Ulm, and Harvard Medical School. Education & Training His formative training began with undergraduate studies in Philosophy and Art History before he read medicine in Freiburg, Glasgow, Toronto and at the University of Massachusetts, earning his MD in 1984. Post-doctoral fellowships followed at Beth Israel Hospital & Harvard Medical School and the Università degli Studi di Milano, after which he obtained his German Habilitation (D.Sc. equivalent) from Ulm University in 1992 and board certifications in Gastroenterology and in Biochemistry. Research Interests His laboratory focuses on the pathophysiology, cell biology and genetics of pancreatic disorders . Landmark contributions include: identification of the pancreatic acinar cell as the primary injury site in pancreatitis, discovery of transient pancreatic duct obstruction and missorted endocytosis as initiating events in gallstone pancreatitis, elucidation of calcium-mediated protease activation and lysosomal enzyme involvement, demonstration of magnesium’s ability to block trypsin activation (now in clinical trials), characterisation of immune-cell (macrophage/NLRP3 inflammasome) roles in onset and severity of pancreatitis, genetic risk stratification (ABO-B, FUT2) and metabolomic biomarker signatures distinguishing pancreatitis from cancer, establishment of the exocrine pancreas as a key regulator of intestinal microbiota. These studies remain deliberately translational, bridging bench to bedside. Scientific Recognition Professor Lerch’s work has been honoured with numerous international awards, including: American Pancreatic Association Lifetime Achievement Award (2021) George-Palade-Prize in Cell Biology (2018) Lifetime Achievement Award of the European Pancreatic Club (2016) Elected Member of Academia Europaea (2016) Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow (2001) and many named lectureships and honorary memberships worldwide. Leadership & Service Beyond his institutional roles he has been: President of the German Gastroenterological Society (DGVS, 2011-2017) President of the German Society of Internal Medicine (DGIM, 2021-2022) Secretary and later President of the European Pancreatic Club Associate Editor of Gut and editorial board member of leading journals Member of the German National Council of Science and Humanities (Wissenschaftsrat), appointed by the Federal President. His laboratory continues to be continuously funded, translating mechanistic insights into improved diagnostics and therapies for patients with pancreatic diseases.

• Neuroscience
• Cardiology
• Neurovascular Biology
• +۳ مورد دیگر

Lulu Lu is a Researcher in the Department of Mathematics at Michigan State University. Her research focuses on neurovascular interactions, particularly exploring the bidirectional relationships between neurological conditions and cardiovascular health. Key areas include vascular dementia pathophysiology, cardiotoxicity mechanisms in chemotherapy, and the role of microbiota in cardiac dysfunction. Utilizing mouse models, her work examines molecular pathways such as adenylyl cyclase regulation, endothelial nitric oxide synthase (eNOS) deficiency, and sympathetic nervous system activity. Recent studies investigate how chronic cerebral hypoperfusion exacerbates cardiac and renal dysfunction, as well as the therapeutic potential of β-blockers like metoprolol in hemorrhagic stroke scenarios. Her publications highlight interdisciplinary approaches combining neuroscience, cardiology, and pharmacology to address comorbid conditions.

• Cardiovascular Science
• Heart Failure
• Cardiac Remodeling
• +۲ مورد دیگر

Dr. Alexander Johnston is a Researcher in Cardiovascular & Metabolic Health at the University of Glasgow . His work focuses on cardiac diseases, particularly heart failure and cardiac remodeling mechanisms. Grants: Medical Research Council (2024) for mouse microsurgery techniques His research explores: Molecular pathways in heart failure (e.g., Runx1 targeting) Cellular responses to acute exercise in cardiac models Calcium cycling and contractility dynamics Recent publications highlight his contributions to translational cardiovascular research and cardiac cell physiology.

Sheon Samjiمشاهده پروفایل

پژوهشگر ارشد

• Molecular Biology
• Proteomics
• Cardiovascular Disease
• +۳ مورد دیگر

Dr. Sheon Samji is a Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health (SCMH). Her expertise lies in molecular biology, proteomics, and the study of cardiovascular and renal diseases. She holds a BSc/MSc in Biotechnology from the University of Pune and a PhD in Biochemical Sciences from CSIR-National Chemical Laboratory (India). Her research focuses on the molecular mechanisms of hypertension and kidney dysfunction, particularly the role of uromodulin in salt-sensitive conditions. Dr. Samji has conducted groundbreaking work on uromodulin's role in kidney and cardiovascular health, including its response to environmental factors like salt intake and pregnancy. Education: BSc Biotechnology, University of Pune, India MSc Biotechnology, University of Pune, India PhD in Biochemical Sciences, CSIR-National Chemical Laboratory, India Research Interests: Dr. Samji's work centers on understanding the molecular basis of cardiovascular and renal diseases. Her key areas include: Uromodulin's role in hypertension and kidney function Salt-sensitive mechanisms in cardiovascular disease Proteomic biomarker discovery for pregnancy complications Renal pathophysiology in hypertensive conditions Grants & Awards: Newton International Fellowship (Royal Society, 2018–2020) CSIR Research Fellowship (Govt of India, 2011–2016) Commonwealth Split-Site Scholarship (2015–2016) Teaching & Mentorship: She mentors PhD students and teaches proteomics courses for Masters programs. She actively promotes equality and mental health awareness within SCMH. Labs & Collaborations: Her work involves collaborations on the African-PREDICT study, exploring urinary peptidomics for cardiovascular risk assessment.

• Neurosciences
• Pain
• Behavioural Neuroscience
• +۹ مورد دیگر

Dr David Mor is a Lecturer in Neuroanatomy within the School of Medical Sciences at the University of Sydney, specializing in the Biomedical Sciences department. His research focuses on the interplay between neuropathic pain, stress, and neural circuitry, particularly examining dopamine and serotonin dynamics, glial activation, and corticotropin-releasing factor (CRF) receptor mechanisms in rodent models. Keywords: Behavioural neuroscience, Neurosciences, Pain Themes: Neurosciences and Mental Health His work explores how peripheral nerve injuries alter brain chemistry, affecting cognitive flexibility, motivation, and stress responses. Recent studies investigate CRF-receptor1 modulation, SOD1 pathology in Parkinson's models, and vitamin D's role in osteoarthritis. Key collaborations include researchers like Dr. Julie Kang and Professor Kim Keay. Publications highlight trends in Neuroinflammation (glial activation in periaqueductal gray) Dopamine signaling in stress and pain CRF receptor mechanisms in cognitive flexibility Vitamin D and musculoskeletal disorders Neurotrophic factor expression in prefrontal cortex Current research students: Anne LI investigates biomarkers of neurodegenerative disease.

• Auditory Neuroscience
• Molecular Biology of Deafness
• Genetics of Hearing Disorders
• +۳ مورد دیگر

Dr Prathamesh Thangaraj Nadar Ponniah is a Research Fellow at the MDNL group within the School of Medical Sciences , University of Sydney , affiliated with the Kolling Institute . His work focuses on the molecular mechanisms underlying auditory disorders with translational applications. Research Focus: Pathophysiology of Meniere's disease, genetics of hearing loss, and molecular biology of inner ear development Key Approaches: Mouse models, cellular/molecular studies, and single-cell analysis Recent publications highlight his expertise in RNA-binding proteins, cochlear regeneration, and noise-induced hearing loss vulnerability. His research has attracted multiple competitive travel awards and research grants. Scientific Honors 2024 Research Support Grant (Royal North Shore Hospital) 2018 MBHD Travel Award (Göttingen, Germany) 2017 Constantiner Travel Scholarship (Tel Aviv, Israel) 2015 Aegean Conference Travel Award (Crete, Greece) 2015 Third Prize at Technion's Inter-Lab Competition 2014 Best Proposal at Technion's Inter-Lab Competition Dr Nadar Ponniah supervises students including Pablo Cruz-Granados, with a focus on single-cell multiome analysis of immune responses in Meniere's disease patients. His work contributes to the Neurosciences and Mental Health theme at his institution.